50 results
8-K
AADI
Aadi Bioscience Inc
7 Nov 19
Aerpio Reports Third Quarter 2019 Financial Results and Provides Business Update
7:13am
vesting. The employment agreement also reaffirms the previously disclosed cash retention payment to Ms. Marek, which is expected to be paid at the end … of the second quarter in fiscal year 2020, in the amount of $120,000 (the “Retention Bonus”). Ms. Marek shall not be eligible to receive
8-K
AADI
Aadi Bioscience Inc
16 May 19
Departure of Directors or Certain Officers
4:49pm
. Rogers and any other person pursuant to which he was appointed as an officer of the Company.
Employee Retention Matters
On May 14, 2019, the Board … realignment plan in April 2019.
The Board of Directors of the Company approved cash retention payments to its salaried employees, which are expected
8-K
EX-10.1
AADI
Aadi Bioscience Inc
7 Nov 19
Aerpio Reports Third Quarter 2019 Financial Results and Provides Business Update
7:13am
and (iii) any retention or severance notice.
WHEREAS, the Company desires to continue to employ the Executive and the Executive desires to continue … March 15th of the next succeeding year.
(c)Equity. The equity awards held by the Executive, including without limitation the Retention Grant (as defined
8-K
AADI
Aadi Bioscience Inc
1 Feb 21
Cost Associated with Exit or Disposal Activities
5:20pm
by reference to the complete text of such amendment, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K.
Employee Retention Matters … approved cash retention payments to its salaried employees, with 50% payable upon shareholder approval of a strategic transaction and the remaining
8-K
AADI
Aadi Bioscience Inc
18 Oct 19
Departure of Directors or Certain Officers
5:27pm
of the Company’s common stock on the Nasdaq Stock Market on the Grant Date.
Additionally, on May 14, 2019, the Board granted a retention stock option … termination date. On May 14, 2019, the Board also approved a cash retention payment to Ms. Marek, which is expected to be paid at the end of the second
8-K
EX-14.1
e7h4 cy3j
26 Aug 21
Entry into a Material Definitive Agreement
9:36pm
8-K
EX-99.1
h8dxxnimqebhw
26 Aug 21
Entry into a Material Definitive Agreement
9:36pm
PREM14A
0lyl7
21 Jun 21
Preliminary proxy related to merger
7:31am
DEFM14A
212b8w73qv0 11qb8y
8 Jul 21
Proxy related to merger
9:24am
8-K
EX-10.1
0sck5k
2 Oct 23
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
8:30am
PRE 14A
y3oxpme t93evw
17 Apr 20
Preliminary proxy
4:46pm
8-K
EX-10.11
6zf6oh4xr2c
26 Aug 21
Entry into a Material Definitive Agreement
9:36pm